Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

American journal of medical genetics. Part A - 30 Apr 2003

Botkin Jeffrey R, Smith Ken R, Croyle Robert T, Baty Bonnie J, Wylie Jean E, Dutson Debra, Chan Anna, Hamann Heidi A, Lerman Caryn, McDonald Jamie, Venne Vickie, Ward John H, Lyon Elaine

Abstract excerpt

Mutations in the BRCA1 gene are associated with an increased risk of breast and ovarian cancer in carrier women. An understanding of behavioral responses to BRCA1 mutation testing by mutation carriers and non-carriers is important to guide the clinical application of this new technology. This study examined the utilization of genetic testing for a BRCA1 mutation in high-risk individuals and the response of tested...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to CA-125 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Mammography

Share to Mass Screening

Share to Mastectomy

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 12673648
DOI: 10.1002/ajmg.a.10102

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.PMID 12673648Read ↗

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.Semantic proximity Read ↗

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers.Semantic proximity Read ↗

BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications.Semantic proximity Read ↗

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.Semantic proximity Read ↗

Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.Semantic proximity Read ↗

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Semantic proximity Read ↗

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.Semantic proximity Read ↗

Risk management options elected by women after testing positive for a BRCA mutation.Semantic proximity Read ↗

Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.